Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie
Franc Llorens(Universitat Autònoma de Barcelona), Inga Zerr(German Center for Neurodegenerative Diseases), Katrin Thüne(Biomedical Research Networking Center on Neurodegenerative Diseases), Peter Lange(Universitätsmedizin Göttingen), Rosa Bolea(Universidad de Zaragoza), Ingolf Lachmann, Juan José Badiola(Universidad de Zaragoza), Anna Villar‐Piqué(Universitätsmedizin Göttingen), Matthias Schmitz(University of Göttingen), Angela da Silva Correia(German Center for Neurodegenerative Diseases), Tomás Barrio(Universidad de Zaragoza)
Cited by 21
Related Papers
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
|Annals of Neurology|1999|1.4k
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
|Molecular Neurodegeneration|2017|268
Age at onset in genetic prion disease and the design of preventive clinical trials
|Neurology|2019|111
Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis
|Science Immunology|2021|60
Detection of Prion Protein Seeding Activity in Tear Fluids
|New England Journal of Medicine|2023|35